12,13-DiHOME

CAS No. 263399-35-5

12,13-DiHOME ( —— )

Catalog No. M37967 CAS No. 263399-35-5

12,13-DiHOME is a stimulator of Brown adipose tissue (BAT), as well as a thermogenic lipokine that activates BAT in response to cold.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    12,13-DiHOME
  • Note
    Research use only, not for human use.
  • Brief Description
    12,13-DiHOME is a stimulator of Brown adipose tissue (BAT), as well as a thermogenic lipokine that activates BAT in response to cold.
  • Description
    12,13-DiHOME is a stimulator of Brown adipose tissue (BAT), as well as a thermogenic lipokine that activates BAT in response to cold.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    263399-35-5
  • Formula Weight
    314.46
  • Molecular Formula
    C18H34O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCC(C(C/C=C\CCCCCCCC(O)=O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lynes MD, et al. The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue. Nat Med. 2017 May;23(5):631-637.
molnova catalog
related products
  • 24-Methylene cycloar...

    24-Methylenecycloartanyl ferulate, a compound belonging to the γ-oryzanol family, demonstrates the ability to enhance parvin-beta expression within human breast cancer cells.

  • LRE1

    LRE1 is a specific and allosteric soluble adenylyl cyclase inhibitor.

  • Phenazoline

    Argireline a synthetic peptide which is patterned from the N-terminal end of the protein SNAP-25 can both reduce the degree of existing facial wrinkles and demonstrate effectively against their development.